Format

Send to

Choose Destination
See comment in PubMed Commons below
Depress Anxiety. 2012 Dec;29(12):1043-9. doi: 10.1002/da.21993. Epub 2012 Aug 29.

Self-report and clinician-rated measures of depression severity: can one replace the other?

Author information

1
Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada. rudolf.uher@kcl.ac.uk

Abstract

BACKGROUND:

It has been suggested that clinician-rated scales and self-report questionnaires may be interchangeable in the measurement of depression severity, but it has not been tested whether clinically significant information is lost when assessment is restricted to either clinician-rated or self-report instruments. The aim of this study is to test whether self-report provides information relevant to short-term treatment outcomes that is not captured by clinician-rating and vice versa.

METHODS:

In genome-based drugs for depression (GENDEP), 811 patients with major depressive disorder treated with escitalopram or nortriptyline were assessed with the clinician-rated Montgomery-Åsberg Depression Rating Scale (MADRS), Hamilton Rating Scale for Depression (HRSD), and the self-report Beck Depression Inventory (BDI). In sequenced treatment alternatives to relieve depression (STAR*D), 4,041 patients treated with citalopram were assessed with the clinician-rated and self-report versions of the Quick Inventory of Depressive Symptomatology (QIDS-C and QIDS-SR) in addition to HRSD.

RESULTS:

In GENDEP, baseline BDI significantly predicted outcome on MADRS/HRSD after adjusting for baseline MADRS/HRSD, explaining additional 3 to 4% of variation in the clinician-rated outcomes (both P < .001). Likewise, each clinician-rated scale significantly predicted outcome on BDI after adjusting for baseline BDI and explained additional 1% of variance in the self-reported outcome (both P < .001). The results were confirmed in STAR*D, where self-report and clinician-rated versions of the same instrument each uniquely contributed to the prediction of treatment outcome.

CONCLUSIONS:

Complete assessment of depression should include both clinician-rated scales and self-reported measures.

TRIAL REGISTRATION:

ClinicalTrials.gov NCT00021528.

PMID:
22933451
PMCID:
PMC3750710
DOI:
10.1002/da.21993
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley Icon for PubMed Central
    Loading ...
    Support Center